REINSURANCE GROUP OF AMERICA INC
For the period ended Dec 31, 2025. Filed Feb 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 20, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Europe, Middle East and Africa Operations
EMEA operations consist of two major segments: Traditional and Financial Solutions. The Traditional segment primarily provides reinsurance through yearly renewable term and coinsurance agreements on a variety of life, health and critical illness products. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks and, in some markets, group risks. The Financial Solutions segment consists of reinsurance and other transactions associated with longevity closed blocks, payout annuities, capital management solutions and financial reinsurance.
The following table sets forth the EMEA operating results for the periods indicated (dollars in millions). See additional information in the Traditional and Financial Solutions sections.
| For the year ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2025 vs 2024 | |
| Total segment revenues | 3,844 | 3,138 | 706 |
| Total adjusted benefits and expenses | 3,481 | 2,763 | 718 |
| Adjusted operating income before income taxes | $363 | $375 | $(12) |
The decrease in adjusted operating income before income taxes was primarily due to the unfavorable impact of the Company’s annual assumptions update which resulted in a future policy benefits remeasurement loss of $185 million.
The following table sets forth the EMEA Traditional segment operating results for the periods indicated (dollars in millions):
| For the year ended December 31, | ||||
|---|---|---|---|---|
| 2025 · 2024 · 2025 vs 2024 | ||||
| Segment revenues | ||||
| Net premiums | $2,258 | $2,002 | $256 | |
| Net investment income | 129 | 112 | 17 | |
| Investment related gains (losses), net | — | — | — | |
| Other revenues | 10 | 11 | (1) | |
| Total segment revenues | 2,397 | 2,125 | 272 | |
| Adjusted benefits and expenses | ||||
| Adjusted claims and other policy benefits | 2,074 | 1,805 | 269 | |
| Future policy benefits remeasurement (gains) losses | 204 | 48 | 156 | |
| Adjusted interest credited | — | — | — | |
| Policy acquisition costs and other insurance expenses | 111 | 109 | 2 | |
| Other operating expenses | 114 | 133 | (19) | |
| Total adjusted benefits and expenses | 2,503 | 2,095 | 408 | |
| Adjusted operating income before income taxes | $(106) | $30 | $(136) | |
| Key metrics | ||||
| Life reinsurance in force | $1,113.1 billion | $970.4 billion | ||
| Future policy benefits remeasurement (gains) losses | ||||
| Effect of changes in cash flow assumptions | $222 | $40 | ||
| Effect of actual variances from expected experience | $(18) | $8 | ||
| Loss ratio (1) | 101% | 93% | ||
| Policy acquisition costs and other insurance expenses as a percentage of net premiums | 5% | 5% | ||
| Other operating expenses as a percentage of net premiums | 5% | 7% | ||
The decrease in adjusted operating income before income taxes in 2025 was primarily due to the unfavorable impacts of the Company’s annual assumptions review discussed below.
The increase in net premiums was due to increases in business volume on new and existing treaties.
The segment added new life business production, measured by face amount of life reinsurance in force, of $171.8 billion and $119.5 billion during 2025 and 2024, respectively.
The increase in the loss ratio was primarily due to unfavorable assumption updates attributable to updated long-term mortality assumptions in the U.K.
During the third quarter of 2025, the Company completed its annual assumptions review resulting in a net unfavorable assumption update totaling $222 million, primarily due to updated mortality assumptions in the U.K. to reflect deterioration in mortality improvements and ongoing challenges within the healthcare system. The 2024 annual assumptions update resulted in a loss of $5 million in the third quarter of 2024. See Note 5 – “Future Policy Benefits” for additional information.
The following table sets forth the EMEA Financial Solutions segment operating results for the periods indicated (dollars in millions):
| For the year ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2025 vs 2024 | |
| Segment revenues | |||
| Net premiums | $959 | $660 | $299 |
| Net investment income | 435 | 319 | 116 |
| Investment related gains (losses), net | 2 | — | 2 |
| Other revenues | 51 | 34 | 17 |
| Total segment revenues | 1,447 | 1,013 | 434 |
| Adjusted benefits and expenses | |||
| Adjusted claims and other policy benefits | 893 | 562 | 331 |
| Future policy benefits remeasurement (gains) losses | (37) | 3 | (40) |
| Adjusted interest credited | 26 | 30 | (4) |
| Policy acquisition costs and other insurance expenses | 9 | 8 | 1 |
| Other operating expenses | 87 | 65 | 22 |
| Total adjusted benefits and expenses | 978 | 668 | 310 |
| Adjusted operating income before income taxes | $469 | $345 | $124 |
| Key metrics | |||
| Future policy benefits remeasurement (gains) losses | |||
| Effect of changes in cash flow assumptions | $(24) | $3 | |
| Effect of actual variances from expected experience | $(13) | $— | |
The increase in adjusted operating income before income taxes in 2025 was primarily due to increases in net investment income, growth in closed blocks longevity business and increases in future policy benefits remeasurement gains as a result of the Company’s annual assumptions update discussed below.
The increase in net premiums was primarily due to increased volumes on new and existing treaties.
The increase in net investment income was primarily due to an increase in invested assets supporting the segment.
The increase in adjusted claims and other policy benefits was the result of increased volumes of closed block longevity business and asset-intensive transactions.
During the third quarter of 2025 and 2024, the Company completed its annual assumptions review resulting in a net favorable assumption update totaling $24 million in the third quarter of 2025, primarily due to updated longevity based mortality in the U.K. The 2024 annual assumptions update resulted in a loss of $3 million in the third quarter of 2024. See Note 5 – “Future Policy Benefits” for more information.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.